Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey

Published:2015-05-19 Issue:1 Volume:14 Page:
ISSN:1476-511X
Container-title:Lipids in Health and Disease
language:en
Short-container-title:Lipids Health Dis

Author:

Krempf Michel,Simpson Ross J,Ramey Dena Rosen,Brudi Philippe,Giezek Hilde,Tomassini Joanne E,Lee Raymond,Farnier Michel

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12944-015-0037-y.pdf

Reference49 articles.

1. Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N: Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170, 000 participants in 26 randomised trials. Lancet. 2010, 376: 1670-81.

2. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106: 3143-421.

3. Perk J, De BG, Gohlke H, Graham I, Reiner Z, Verschuren WM: European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Atherosclerosis. 2012, 223: 1-68.

4. Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Lloyd-Jones DM, Blum CB: 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. 2014, 63: 2889-934.

5. Catapano AL, Reiner Z, De BG, Graham I, Taskinen MR, Wiklund O: ESC/EAS guidelines for the management of dyslipidaemias the task force for the management of dyslipidaemias of the European society of cardiology (ESC) and the European atherosclerosis society (EAS). Atherosclerosis. 2011, 217: 3-46.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-Lowering Medications for Managing Dyslipidemia: A Narrative Review;Cureus;2024-07-23

2. Adherence to Current Dyslipidemia Guideline in Patients Utilizing Statins According to Risk Groups and Gender Differences: The AIZANOI Study;The Anatolian Journal of Cardiology;2024

3. Physicians' perceptions and beliefs on the current dyslipidemia management practices within Saudi Arabia;Saudi Pharmaceutical Journal;2023-10

4. hyperlipidemia-post-initiation-of-nilotinib-among-chronic-myeloid-leukemia-patients-in-a-tertiary-hospital-of-malaysia;Malaysian Journal of Pharmacy;2022-06-01

5. Impact of the 2016 Canadian Lipid Guidelines on Daily Practice at a Community Hospital;Canadian Journal of Diabetes;2022-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3